StartSe Interview

StartSe Interview

Our colleague, Rui Cavendish, was quoted by StartSe, the Brazilian “Tech Crunch”, on his thoughts about the future of outbound M&A and investments by Chinese companies.

In his interview for StartSe, our Partner shared his vision that outbound M&A from China will be dominated by the China 500 companies (especially the BAT companies and large SOEs), in high technology sectors, or companies that possess outstanding IP or have a strategic importance to China, and that SMEs will focus on acquiring clients directly through tenders and organic expansion.

For the full original post in Portuguese, please follow this link: https://lnkd.in/efmE9vW

If you would like a translated version, please feel free to contact our team.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission